FindTrial
Sign In

Analysis of Clinical Characteristics and Risk Factors of Moyamoya Disease in Han Nationality

Analysis of the clinical characteristics and risk factors of moyamoya disease in Han nationality

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100054021
Enrollment
Unknown
Registered
2021-12-06
Start date
2019-01-01
Completion date
Unknown
Last updated
2022-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moyamoya disease

Interventions

moyamoya disease group vs. health control group:N/A

Sponsors

The Second Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged >= 18 years; 2.The diagnosis complies with the diagnosis of adult MMD in Chinese expert diagnosis and treatment in 2017.

Exclusion criteria

Exclusion criteria: 1.Liver function indicators were severely abnormal, with three times the upper limits of ALT and or AST normality; 2.Severe abnormal renal diseases such as renal failure, nephrotic syndrome, renal insufficiency, nephritis, etc. 3.Merge other system serious abnormal.

Design outcomes

Primary

MeasureTime frame
lipoprotein A;SBP;DBP;BMI;Lymphocyte count;Platelet count;Glucose;albumin;creatinine;uric acid;triglyceride;total cholesterol;high-density lipoprotein (HDL) cholesterol;low-density lipoprotein (LDL) cholesterol;apolipoprotein A;apolipoprotein B;homocysteine;—

Countries

China

Contacts

Public ContactXinlei Yang
yxl2251259@163.com+86 15079150076

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026